ANALYST-UPGRADE ·Filed Jun 24, 2026

MRK

Merck & Co., Inc.
BULLISH
Impact 2/10
Processed3mo ago SECanalyst-MRK-cicc-20260624
CICC initiates coverage on MRK at Outperform

Price Chart

Loading chart...

Executive Summary

CICC initiates coverage on MRK at Outperform

Impact Score

Base Score
2/7
LLM Adjustment
+0
Final Score
2/10

Consensus & Targets

Buy / Strong Buy
25 (69%)
Hold
11
Sell / Strong Sell
0
Total Analysts
27
Mean PT
$130.11
Median PT
$135.00
High PT
$150.00
Low PT
$100.00
Current Price
$119.60
Implied Upside
+8.8%

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-06-24CICCinitiateOutperform$138.00
2026-05-01Wells FargomaintainOverweight$145.00
2026-04-13UBSmaintainBuy$145.00
2026-04-06JP MorganmaintainOverweight$135.00
2026-03-30RBC CapitalreiterateOutperform$142.00
2026-03-20CitigroupmaintainNeutral$125.00
2026-03-12Wells FargomaintainOverweight$150.00
2026-02-25RBC CapitalinitiateOutperform$142.00
2026-02-20BarclaysinitiateOverweight$140.00
2026-02-09Freedom BrokermaintainHold$110.00

Firm Track Record — CICC

CICC accuracy: 55% on 31 calls | avg return: 1.4%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 12 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
Deutsche Bank100%2/29.7%top tier
BMO Capital50%2/40.7%below average
Morgan Stanley43%3/72.8%below average
Wells Fargo40%2/53.8%below average
B of A Securities33%1/3-0.2%below average
Guggenheim25%1/4-7.8%below average
Truist Securities20%1/5-10.3%below average
Cantor Fitzgerald9%1/11-5.5%below average
Barclays0%0/2-7.6%below average
Berenberg0%0/211.6%below average

Earnings Estimates

Next earnings: Aug 4, 2026

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
+1q$2.31$2.11 — $2.56$17.5B↑1 ↓0
0y$2.74$2.61 — $2.92$66.8B↑0 ↓0
+1y$9.56$8.90 — $9.87$70.2B↑0 ↓0
0q$-0.15$-0.33 — $0.01$16.4B↑0 ↓0

Cross-Platform Signals

Institutional
Pacer Advisors, Inc. — near_exit (-83.2%)
Institutional
NORGES BANK — exit (-100%)
Institutional
MATRIX ASSET ADVISORS INC/NY — trim (-41.6%)
Short Interest
Short: 2,483,659 | Exempt: 3,589 | TRF Vol: 4,427,571 | Short Ratio: 56.1% | Off-exchange volume (dark pool + OTC)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

Report based on filing metadata.

20 reports for MRK
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+20▲ +18.67%Aug 6, 2026
Filters
Rows
Reports for MRK — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
Court Ruling
NEUTRAL ★ 1/10
$143.93 $146.87▲ +2.04%▲ +2.26%$143.91 (−0.01%)
Sep 9, 2026
23d ago
Court Ruling
NEUTRAL ★ 1/10
$147.53 $144.91▼ −1.78%▼ −1.12%$143.91 (−2.45%)
Aug 27, 2026
5w ago
Court Ruling
NEUTRAL ★ 1/10
$149.54 $152.34▲ +1.87%▲ +1.60%$143.91 (−3.76%)
Aug 24, 2026
5w ago
Court Ruling
BEARISH ★ 5/10
$150.66 $147.73▲ +1.95%▲ +2.42%$143.91 (+4.48%)
Aug 20, 2026
6w ago
ANALYST-UPGRADE
MIXED ★ 5/10
$148.99 $149.54▲ +0.37%▼ −0.75%$143.91 (−3.41%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.84 $152.55▲ +12.30%▲ +13.67%$143.91 (+5.94%)
Aug 13, 2026
7w ago
Court Ruling
NEUTRAL ★ 3/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.91 (+6.17%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.91 (+6.17%)
Aug 12, 2026
7w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.91 (+8.27%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.91 (+8.27%)
Showing 10 of 20

US Market Status

Market Open — Closes in 49m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 24, 2026